Cite
HARVARD Citation
Nishino, M. et al. (2021). Tumor Growth Rate After Nadir Is Associated With Survival in Patients With EGFR-Mutant Non–Small-Cell Lung Cancer Treated With Epidermal Growth Factor Receptor Tyrosine Kinase Inhibitor. JCO precision oncology. p. . [Online].